When Japanese doctors Ryuji Ueno and Sachiko Kuno came to Bethesda two decades ago, they already had a drug company back home. They founded what would become Sucampo entirely with their own capital in 1996 to see if they could sell treatments to a much larger American market.
Two decades later Sucampo is under new leadership, and is buying out its Japanese predecessor R-Tech Ueno for $278 million in cash and stock.
{iframe}http://www.washingtonpost.com/business/capitalbusiness/bethesda-drug-company-sucampo-to-buy-its-japanese-predecessor-and-manufacturing-arm/2015/08/26/05ec9344-4c2b-11e5-84df-923b3ef1a64b_story.html{/iframe}